Status:
UNKNOWN
Evaluation of Corneal Endothelial Changes After Uneventful Phacoemulsification in Diabetic and Non-diabetic Patients in Relation to the Level of Glcosylated Hemoglobin Level
Lead Sponsor:
Marwa Ahmed
Conditions:
Corneal Endothelial Changes After Phacoemulsification
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
Evaluation of corneal endothelial changes after uneventful phacoemulsification in diabetic and non-diabetic patients using specular biomicroscopy in relation to the level of glcosylated hemoglobin lev...
Detailed Description
86 patients will be divided into two equal groups of diabetic and non-diabetic patients will undergo phacoemulsification of cataract will be evaluated thier endocelium before surgery and 3 weeks after...
Eligibility Criteria
Inclusion
- Diabetics and non-diabetic patients undergo cataract surgery
- Age between 50-60 years old
- Corrected distance visual acuity\<0.4
- Gender: both genders.
Exclusion
- Chronic Ocular diseases (glaucoma,uveitis, amblyopia, strabismus,keratoconus, corneal opacity).
- corneal dystrophy History of previous keratitis or viral corneal infection. Corneal dystrophy Ocular trauma. Previous ocular surgery. Complicated cataract surgery
Key Trial Info
Start Date :
May 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 17 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05426590
Start Date
May 20 2022
End Date
November 17 2022
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt